LESLIE J. DEGROOT, M.D.; MAUREEN REILLY, R.N., B.S.N.
We compared the utility of lower (30 mCi) and higher (50 to 60 mCi) doses of 131I used to ablate residual thyroid tissue after thyroidectomy for carcinoma. Whole body scans were done using 1 mCi 131I, 3 weeks after withdrawal of triiodothyronine. Patients had received ablation therapy within 3 days after scanning, and one or more subsequent scans were analyzed. Forty-eight patients were treated to ablate residual thyroid tissue that was presumed to be normal. Among 18 patients given the lower dose of 131I as outpatients, 15 had successful ablation and three needed a second administration; all 30 patients treated with the higher dose had successful ablation. Seventeen additional patients, presumed to have residual cancer, received 50 to 150 mCi; and six needed treatment. Although 1 dose of 50 to 60 mCi 131I provides more certain ablation, use of the usually effective 30-mCi dose for initial ablation is justified by the convenience of outpatient administration, the lower expense, and the lower whole-body radiation dose.
Learn more about subscription options.
Register Now for a free account.
DEGROOT LJ, REILLY M. Comparison of 30- and 50-mCi Doses of Iodine-131 for Thyroid Ablation. Ann Intern Med. 1982;96:51–53. doi: 10.7326/0003-4819-96-1-51
Download citation file:
Published: Ann Intern Med. 1982;96(1):51-53.
Endocrine and Metabolism, Hematology/Oncology, Thyroid Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only